BioStem Technologies, Inc. (BSEM) Q4 2024 Earnings Call Transcript

2025-04-14 19:03:54 ET

BioStem Technologies, Inc. (BSEM)

Q4 2024 Earnings Conference Call

April 14, 2025 04:30 PM ET

Company Participants

Adam Holdsworth - Investor Relations

Jason Matuszewski - Chief Executive Officer

Michael Fortunato - Chief Financial Officer

Conference Call Participants

Swayampakula Ramakanth - H.C. Wainwright

Erik Voss - Mission Vertical

Mitchell Sacks - Grand Slam

Richard Huebner - GVC Capital

Presentation

Operator

Please stand by. Good day everyone and welcome to the BioStem Technologies Fourth Quarter and Full Year 2024 Conference Call. Just a reminder that today's call is being recorded. At this time I would like to hand things over to Mr. Adam Holdsworth. Please go ahead.

Adam Holdsworth

Good afternoon everyone, and thank you for joining our conference call to discuss BioStem's fourth quarter and full year 2024 financial results and corporate highlights. Leading the call today will be Jason Matuszewski, the company's Founder and Chief Executive Officer; and Mike Fortunato, the company's Chief Financial Officer.

Before we begin, I'd like to remind everyone that our remarks today may contain forward-looking statements based on the current expectations of management, which involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated. These risks are described in the company's filings with the over-the-counter market. You are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date made and may change at any time.

While we may update or revise these statements from time-to-time, the company undertakes no commitment to do so unless required by applicable securities law. This call also includes references to certain financial measures that are not calculated in accordance with Generally Accepted Accounting Principles or GAAP. We generally refer to these as non-GAAP financial measures. Reconciliation of these non-GAAP financial measures to the most comparable GAAP measures are available in the company's earnings press release on the Investor Relations section of BioStem's website....

Read the full article on Seeking Alpha

For further details see: